THE BRIO TEAM
"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."
- Margaret Mead
BRIOTECH FOUNDER, CEO
Dan Terry is an inventor and the founder of Briotech, Inc. With 30+ years of experience in design-for-manufacturability of electro-mechanical and mechanical devices, Dan specializes in product and component development, start-up, ramp-up, continuous improvement and supply chain management. He provides solutions in design, manufacturing processes, supplier selection and management, and component supply. Dan’s specialties include 'change agent' review, LED thermal solutions, thermal products, alternative energy in micropower, hydro-power, ethanol distillation, solar, clean coal, hydrogen, IP review and IP development. After four years in development at Danterry, Inc., Briotech, Inc. was spun out as a manufacturer of stable, ultra-pure Hypochlorous Acid (HOCl) for biocide products, the cosmetics industry, animal and human healthcare, hospital disinfection, pathogen control, and the agriculture industries. Briotech’s patent-pending innovations include new electrolysis technology, development of mobile HOCl factory systems for disaster relief and pathogen disinfection spray and fogging systems.
BRIOTECH FOUNDER, CAO
Cynthia Varela is the founder of Briotech, Inc. She has worked alongside Dan Terry for the past 27 years, running Danterry, Inc. and in the start-up of Briotech. She has over 33 years of experience in administrative and business management operations. Her structured and supportive nature coupled with her enthusiastic and entrepreneurial spirit, have proven key success throughout her career and in running her own companies. Cynthia carries with her a keen sense of company vision for Briotech, and specializes in strategic and thoughtful carry-through of that vision through customer service.
BRIOTECH PRESIDENT, CHIEF COMMERCIAL OFFICER
Rick has been an executive sales and business development leader, President or CEO of several firms and has achieved significant growth in multiple roles. He played a key role in the growth of HaloSource from a $3 million firm to a revenue run rate beyond $16 million and a successful IPO, recently led water tech company Puralytics through a fund raise, restructure and sale process, and has been a founder, executive, advisor, mentor or consultant to multiple clean technology and consumer product companies. Rick has experience in consumer goods, global business development and licensing of technology and is deeply committed to the key mission of Briotech.
JEFF WILLIAMS, PhD, BVSc, MRCVS
BRIOTECH CHIEF SCIENCE OFFICER
Dr. Williams had a long career in academic microbiology and infectious diseases, retiring after 27 years from his position as Professor Emeritus of Microbiology and Molecular Genetics, Michigan State University to found a biotechnology start-up, HaloSource, Inc., in Seattle, WA in 1998. Retiring again in 2014, he has remained active as technical advisor to several companies in the PNW region, specializing in the areas of antimicrobial chemistry and disinfection. Author of over 200 scientific papers and textbook chapters, he served four years as a member of the Board of Counselors to the US-NIH Institute of Allergy and Infectious Diseases, and has been a frequent consultant to the World Health Organization of the UN in Geneva, Switzerland. Jeff was elected Fellow of the American Association for the Advancement of Science (AAAS) in 1996, and served as retained consultant to first Merck, Inc. (1980-1982), then Pharmacia (now Pfizer, Inc.) (1983-1999) on therapeutic drug discovery and development. He has a long standing interest in tropical infectious diseases, starting with his appointment as staff scientist for WHO in Argentina 1968-71, and for 15 years directed a collaborative NIH-funded Program Project on Infectious Diseases in Sudan. He holds degrees in Veterinary Science (BVSc) from the University of Bristol, UK (1964), and Pathobiology (PhD) from the University of Pennsylvania (1968), where he was a Fulbright Scholar (1964-1968).
ERIC RASMUSSEN, MD, MDM, FACP
BRIOTECH CHIEF MEDICAL OFFICER
Dr. Rasmussen is a global expert, consultant and teacher in disaster medicine and response technologies in the US, China, and Germany. He has 25 years of experience as a Navy physician with multiple combat tours in Bosnia, Iraq and Afghanistan, and more conventional medical experience as an Intensive Care Unit Director and Chairman of an academic Department of Medicine. He spent nine years as a Principal Investigator with the Defense Advanced Research Projects Agency (DARPA) and is now the CEO of Infinitum Humanitarian Systems, a humanitarian sciences consulting group with projects in Mexico, Tanzania, Latvia, Nepal, the Philippines, and China. He also leads the global disaster response team for the Roddenberry Foundation, supported by the “Star Trek” franchise, and holds multiple academic, advisory, and public service appointments.
Jeremy Stone, MD, MBA, FRSA: Jeremy is a physician, entrepreneur and financier, with international interests in life sciences, aviation, transport, structured finance, healthcare reform and strategy. Trained in the British National Health Service, he has worked globally as investor, Chair, CFO, CEO and COO, yet inside remains a physician with a passion for disruptive life-enhancing innovation.
Bryan Hurd, CISSP, CISA, CISM, CCCI, CCFT: Bryan is the Director of Advanced Analytics Cybercrime Center at Microsoft. Bryan is a global expert in strategic response to terrorism, cybercrime and cyber security with 20+ years of experience in military, government civilian and commercial corporation roles. He founded the first cyber counterintelligence program for the US Navy, was in charge of innovation and national data integration for US watchlisting and was the first director of intelligence for Microsoft’s global cybercrime center.
Caitlin Cameron: Caitlin is the Chairman and CEO of OtoNexus Medical Technologies. She is a highly-accomplished senior executive with 30 years cross-industry expertise in the Life Sciences, Biotech Technology, and IT industries. She is a specialist in building successful start-up companies and taking them through to successful exit. Previously, she held Chair and CEO positions at several Life Sciences and IT companies, building successful businesses and organizations, creating value and maximizing potential in a very short period of time.